Back

Direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: a systematic review and meta-analysis

26 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Platelets and thrombomodulin Thrombosis, Bleeding ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Luiz KUBRUSLY

Heart Institute of Curitiba, Curitiba (Brazil)

7 More presentations in this session

Presentation thumbnail
Human platelets and megakaryocytes express the BPIFB4 protein and their stimulation with the recombinant Longevity-associated variant LAV-BPIFB4 displays anti-aggregating activity.
Doctor E. Ciaglia (Salerno, IT)
Abstract Slides Video
Presentation thumbnail
Pro-inflammatory sensitization of platelets after a mild course of COVID-19 infection
Ms C. Tolksdorf (Oldenburg, DE)
Abstract Slides Video
Presentation thumbnail
Effects of the activated coagulation factor X (FXa) and its protease-activated receptor-2 (PAR2) on colon cancer cell growth in vitro and in vivo
Professor B. Rauch (Oldenburg, DE)
Abstract Slides Video
Presentation thumbnail
Hypercoagulability impairs plaque stability in diabetes-induced atherosclerosis
Miss S. Ambreen (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
S1P receptor-1 signaling reduces arterial thrombosis by upregulation of endothelial thrombomodulin expression
Mrs M. Barcik (Duesseldorf, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Platelets and thrombomodulin

The Event

Event poster

ESC Congress 2023

26 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Direct Oral Anticoagulants versus Vitamin K Antagonists for the management of left ventricular thrombus after myocardial infarction: A meta-analysis
thumbnail
Congress Presentation
Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists
thumbnail
Congress Presentation
Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources